Early research (Phase 1)Ended earlyNCT00543114
What this trial is testing
Dose Escalation Study of Revlimid With Fludarabine-Rituximab for CLL/SLL
Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Leukemia
Dana-Farber Cancer Institute 9